Elastomeric Membrane Surface Treatment for Cell Sheet Formation

Solution Overview

Problem

Existing methods for enhancing cell attachment on silicone-based polymers like PDMS for cell culture are often complex, costly, and involve toxic materials, or require specialized equipment, while current cell sheet formation techniques rely on surface modifications or external stimuli that may not be universally applicable.

Innovation Solution

A method using polyphenols like tannic acid and lignin to treat elastomeric membranes, creating a hydrophilic surface for cell attachment without exogenous ECM components, and employing 3D printing or CNC machining to pattern membranes for controlled cell alignment, allowing for simple, cost-effective, and biocompatible cell sheet formation without the need for toxic substances or specialized equipment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If covalent immobilization of extracellular matrix proteins is used on PDMS surface, then cell attachment is improved, but the process becomes complex and requires toxic materials

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the complex multi-step functionalization process (salinization, linker addition, EDC/NHS, glutaraldehyde, polymer brushes) from the PDMS surface treatment. Instead, it uses a simple plasma treatment followed by incubation with extracellular matrix proteins, removing the harmful intermediate steps while retaining the cell attachment benefit.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the inherent hydrophobicity of PDMS, which was previously a problem causing non-specific protein adsorption, into a beneficial feature. By using plasma treatment to create a temporarily hydrophilic surface that selectively binds extracellular matrix proteins, the original hydrophobic nature of PDMS is preserved in the bulk while the surface gains controlled protein-binding capability.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Reliability

If plasma radiation is used to enhance surface hydrophilicity, then cell attachment is improved, but the effect is short-lived and requires continuous treatment

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent applies plasma treatment as a preliminary activation step that creates reactive groups on the PDMS surface. This preliminary action enables subsequent covalent or strong adsorptive binding of extracellular matrix proteins, creating a stable layer that persists throughout the cell culture process, eliminating the need for continuous plasma treatment.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If dopamine coating is used to improve cell attachment, then cell attachment is enhanced, but the coating is expensive, toxic, and interferes with microscopy

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces expensive, toxic dopamine coatings with inexpensive, biocompatible extracellular matrix proteins (such as collagen, fibronectin, or laminin) that can be easily obtained from biological sources. These proteins provide the necessary cell attachment functionality without the harmful side effects, and their natural biocompatibility eliminates toxicity concerns.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Ease of operation

If PIPAAm grafting is used for cell sheet detachment, then enzyme-free detachment is achieved, but the process requires specialized temperature control equipment

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent employs the natural thermal sensitivity of cell-adherent proteins and the phase behavior of the PDMS-protein complex. By simply cooling the culture to 4°C, the system self-triggered detachment occurs without requiring specialized equipment. The temperature change causes conformational changes in the protein layer that reduce cell attachment, enabling easy peeling of cell sheets.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables efficient, low-cost, and biocompatible cell sheet formation with controlled cell alignment, using reusable membranes and inducing ECM production for stable cell constructs that can be easily detached, applicable to various cell types and species.

Implementation Method 1

A method using polyphenols like tannic acid and lignin to treat elastomeric membranes, creating a hydrophilic surface for cell attachment

Methodology Applied
Scientific EffectHydrophilicity enhancement through polyphenol treatment: Adsorption

Implementation Method 2

employing 3D printing or CNC machining to pattern membranes for controlled cell alignment

Methodology Applied
Scientific Effect3D printing: 3D Printing

Data Source

PatentUS20230399619A1Device and method for making cell sheets
Publication Date: 2023.12.14
  • US20230399619A1 patent drawing
  • US20230399619A1 patent drawing
  • US20230399619A1 patent drawing

AI summary

Systems and methods for growing cells or cell sheets are described. The method may use biocompatible or food-safe materials. The method may allow for cell alignment, optionally in selected patterns, which may be produced by casting a membrane on a 3D printed mold. The method may include surface treatment of an elastomeric membrane. The method may allow for the reuse of the membranes by autoclaving and/or a washing step. The method may create multi-layer cell sheets with an extracellular matrix (ECM) created by the cells, which may be detached from the membrane. Optionally, the cells may be separated from the ECM.